In this episode of the Leap Together podcast, we’re joined by Dr. Raymond Douglas, a world-renowned oculoplastic surgeon and Chief Scientific Officer at Sling Therapeutics. Known for his pioneering work in thyroid eye disease (TED), Dr. Douglas was a lead developer of Tepezza, the first FDA-approved treatment for TED; ushering in a new era of patient-centered innovation.

Dr. Douglas shares how his early work in oncology and immunology laid the foundation for breakthroughs in ophthalmology, and how deeply personal patient experiences inspired him to challenge the limitations of traditional care. We explore his journey from lab research to global impact, the growing role of personalized medicine, and how collaboration, mentorship, and empathy have shaped his mission.

Tune in for a thought-provoking conversation on the future of TED, reducing barriers to clinical trial access, and how translational science, when paired with compassion, can redefine what’s possible in modern medicine.